News

Technology Partners Events

Kytopen and Bio-Techne Collaborate on an Integrated Cellular Engineering Workflow to Expedite Cell Therapy Manufacturing

Kytopen and Bio-Techne announce partnership on an integrated cellular engineering workflow to...
Kytopen
May 08, 2025
Technology Partners

T-CURX GmbH Enters into Technology Access Agreement with Kytopen

Kytopen announces expansion of its partnership program into Europe with its agreement with T-CURX...
Kytopen
February 13, 2025
Technology Partners

Kytopen Enables Significant Advances in Non-viral Cellular Engineering of Monocyte-derived Macrophages

Successful engineering of macrophages is of critical importance for next-generation...
Kytopen
October 22, 2024
Technology Partners

Charles River Comparative Study Reveals that Kytopen’s Flowfect Tx™ Platform Outperforms Conventional Electroporation Platforms

Charles River generated best-in-class data with Kytopen’s Flowfect™ technology in comparative...
Kytopen
September 17, 2024
Technology

Kytopen Receives Prestigious Phase II SBIR Award of $1.6M from the NIAID/NIH to Support Pivotal In Vivo Studies of Engineered Natural Killer Cells

Kytopen awarded competitive phase II SBIR fast-track funding for “Non-Activated Natural Killer...
Kytopen
August 13, 2024
Technology Partners

Kytopen FlowFect™ Platform to Be Used in GMP-Manufacture of an Engineered Cell Therapy – IND Submission and Clinical Study in 2024

Kytopen announces the first implementation of its GMP compliant Flowfect Tx™ cellular engineering...
Kytopen
July 16, 2024
Insider Team

Kytopen names industry executive Kevin Gutshall as Chief Commercial Officer

Kytopen announces appointment of industry executive Kevin Gutshall as Chief Commercial Officer ...
Kytopen
April 09, 2024
Insider Partners Team

Kytopen Announces Technology Access Program

Kytopen Announces Launch of Technology Access Program Supported by an Expanded Applications Team
Kytopen
March 26, 2024